Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 2JX7Y | — |
Priorix administration of only the diluent portion; Priorix administration of only the diluent portion; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 45-year-old male patient who received MMR (Priorix) (batch number 2JX7Y, expiry date 01-JUN-2026) for prophylaxis. On 13-MAY-2025, the patient received Priorix. On 13-MAY-2025, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: Priorix administration of only the diluent portion) and inappropriate dose of vaccine administered (Verbatim: Priorix administration of only the diluent portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 13-MAY-2025 A nurse called to report that a patient was given only the diluent portion of the Priorix vaccine which led to inappropriate preparation of medication and inappropriate dose of vaccine administration. The nurse asked for safety information concerning this situation.